PMEF
PAHC icon

Point72 Middle East FZE’s Phibro Animal Health PAHC Stock Holding History

Point72 Middle East FZE’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,164
Closed -$59.8K – 957
2023
Q4 		$59.8K Buy
+5,164
New +$58.3K ﹤0.01% 1259

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Point72 Middle East FZE's PAHC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Phibro Animal Health (PAHC) in Q1 2024, closing a stake of 5,164 shares — an estimated $59.8K sold.

Point72 Middle East FZE first reported a position in PAHC in Q4 2023 and held it in 1 quarter. The position peaked at $59.8K in Q4 2023. 138 funds tracked by Wall St. Rank hold PAHC as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Phibro Animal Health position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 5,164 Phibro Animal Health shares in Q1 2024, an estimated $59.8K.
  • Point72 Middle East FZE first reported a position in Phibro Animal Health in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's Phibro Animal Health position peaked at $59.8K in Q4 2023.
  • 138 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.